Cargando…

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

Andrew Vernon and co-authors discuss adherence to therapy and its measurement in tuberculosis treatment trials.

Detalles Bibliográficos
Autores principales:	Vernon, Andrew, Fielding, Katherine, Savic, Rada, Dodd, Lori, Nahid, Payam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Collection Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903706/ https://www.ncbi.nlm.nih.gov/pubmed/31821323 http://dx.doi.org/10.1371/journal.pmed.1002884

Ejemplares similares

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
por: Phillips, Patrick P. J., et al.
Publicado: (2019)

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
por: Lienhardt, Christian, et al.
Publicado: (2019)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

Making trials matter: pragmatic and explanatory trials and the problem of applicability
por: Treweek, Shaun, et al.
Publicado: (2009)

Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence
por: Margolis, Karen L., et al.
Publicado: (2022)

Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness
por: Olliaro, Piero L., et al.
Publicado: (2019)

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
por: Dooley, Kelly E., et al.
Publicado: (2019)

A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials
por: Sajobi, Tolulope T., et al.
Publicado: (2018)

Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
por: Davies, Geraint, et al.
Publicado: (2019)

Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19
por: Casey, Jonathan D, et al.
Publicado: (2022)

Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol
por: Jerene, Degu, et al.
Publicado: (2023)

Pragmatic vs explanatory trials: the Pragmascope tool to help measure differences in protocols of mental health randomized controlled trials
por: Tosh, Graeme, et al.
Publicado: (2011)

How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial
por: Selby, Peter, et al.
Publicado: (2012)

Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
por: Brigden, Grania, et al.
Publicado: (2019)

Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis
por: Zatzick, Douglas, et al.
Publicado: (2023)

Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials
por: Imperial, Marjorie Z., et al.
Publicado: (2021)

Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention
por: Lönnroth, Knut, et al.
Publicado: (2014)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
por: Gupta, Amita, et al.
Publicado: (2019)

Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis
por: Fitzpatrick, Claire, et al.
Publicado: (2020)

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
por: Alipanah, Narges, et al.
Publicado: (2018)

Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs
por: Bossie, Cynthia A., et al.
Publicado: (2015)

Explanatory pragmatism: a context-sensitive framework for explainable medical AI
por: Nyrup, Rune, et al.
Publicado: (2022)

Drivers of autochthonous and imported malaria in Spain and their relationship with meteorological variables
por: Sousa, Arturo, et al.
Publicado: (2021)

Outcome measures in post-stroke arm rehabilitation trials: do existing measures capture outcomes that are important to stroke survivors, carers, and clinicians?
por: Duncan Millar, Julie, et al.
Publicado: (2019)

Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions
por: Lienhardt, Christian, et al.
Publicado: (2016)

Statistical methods for non-adherence in non-inferiority trials: useful and used? A systematic review
por: Dodd, Matthew, et al.
Publicado: (2022)

Why is conducting pragmatic clinical trials so important?
por: Esteban, Ignacio, et al.
Publicado: (2022)

Randomised controlled pragmatic clinical trial evaluating the effectiveness of a discharge follow-up phone call on 30-day hospital readmissions: balancing pragmatic and explanatory design considerations
por: Yiadom, Maame Yaa A B, et al.
Publicado: (2018)

Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases
por: Vyas, Hrushikesh, et al.
Publicado: (2022)

How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial
por: Laxy, Michael, et al.
Publicado: (2018)

The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial
por: Glasgow, Russell E., et al.
Publicado: (2021)

Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials
por: Bratton, Daniel J, et al.
Publicado: (2011)

Effectiveness of screening for tuberculosis in HIV: a pragmatic clinical trial
por: Santos, Marcela Lopes, et al.
Publicado: (2021)

A pragmatic view on pragmatic trials
por: Patsopoulos, Nikolaos A.
Publicado: (2011)

Determinants of Judgments of Explanatory Power: Credibility, Generality, and Statistical Relevance
por: Colombo, Matteo, et al.
Publicado: (2017)

Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach
por: Courtright, Katherine R., et al.
Publicado: (2017)

BioSentinel: Validating Sensitivity of Yeast Biosensors to Deep Space Relevant Radiation
por: Liddell, Lauren C., et al.
Publicado: (2023)

A systematic review of measures of adherence to physical exercise recommendations in people with stroke
por: Levy, Tamina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f16f2obj7hf03t2j2l63v59t9d